Molecular and imaging biomarkers of PARP inhibitors for small cell lung cancer

被引：0
|
作者：
Lok, Benjamin H.
机构：
来源：
CANCER RESEARCH | 2024年 / 84卷 / 01期
关键词：
D O I：
10.1158/1538-7445.DNAREPAIR24-IA003
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
IA003
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Target engagement imaging of PARP inhibitors in small-cell lung cancer
    Carney, Brandon
    Kossatz, Susanne
    Lok, Benjamin H.
    Schneeberger, Valentina
    Gangangari, Kishore K.
    Pillarsetty, Naga Vara Kishore
    Weber, Wolfgang A.
    Rudin, Charles M.
    Poirier, John T.
    Reiner, Thomas
    [J]. NATURE COMMUNICATIONS, 2018, 9
  • [2] Target engagement imaging of PARP inhibitors in small-cell lung cancer
    Brandon Carney
    Susanne Kossatz
    Benjamin H. Lok
    Valentina Schneeberger
    Kishore K. Gangangari
    Naga Vara Kishore Pillarsetty
    Wolfgang A. Weber
    Charles M. Rudin
    John T. Poirier
    Thomas Reiner
    [J]. Nature Communications, 9
  • [3] The synergistic potential of PARP inhibitors and irinotecan in small cell lung cancer
    Oh, Songji
    Kim, Miso
    Kim, Soyeon
    Keam, Bhumsuk
    Youk, Jeonghwan
    Kim, Tae Min
    Kim, Dong-Wan
    Heo, Dae Seog
    [J]. CANCER RESEARCH, 2024, 84 (06)
  • [4] Homologous recombination pathway-based biomarkers for treatment of non-small cell lung cancer with PARP inhibitors
    Deraska, Peter V.
    Reavis, Hunter D.
    Labe, Shelby
    D'Andrea, Alan D.
    Kozono, David
    [J]. CANCER RESEARCH, 2017, 77
  • [5] PARP inhibitors in small cell lung cancer: The underlying mechanisms and clinical implications
    Wang, Xueting
    Zeng, Xianhu
    Li, Dan
    Zhu, Chunrong
    Guo, Xusheng
    Feng, Lingxin
    Yu, Zhuang
    [J]. BIOMEDICINE & PHARMACOTHERAPY, 2022, 153
  • [6] In Vivo Characterization of Two PARP Inhibitors Using a Recently Developed PET Imaging Agent in Small Cell Lung Cancer
    Carney, Brandon
    Kossatz, Susanne
    Lok, Benjamin
    Poirier, John
    Weber, Wolfgang
    Rudin, Charles
    Reiner, Thomas
    [J]. JOURNAL OF NUCLEAR MEDICINE, 2016, 57
  • [7] PARP Inhibitors in Small-Cell Lung Cancer: Rational Combinations to Improve Responses
    Knelson, Erik H.
    Patel, Shetal A.
    Sands, Jacob M.
    [J]. CANCERS, 2021, 13 (04) : 1 - 16
  • [8] PARP Inhibitors: An Interesting Pathway also for Non-Small Cell Lung Cancer?
    Levra, Matteo Giaj
    Olaussen, Ken Andre
    Novello, Silvia
    Soria, Jean-Charles
    [J]. CURRENT PHARMACEUTICAL DESIGN, 2014, 20 (24) : 3875 - 3882
  • [9] PARP inhibitors for small cell lung cancer and their potential for integration into current treatment approaches
    Barayan, Ranya
    Ran, Xiaozhuo
    Lok, Benjamin H.
    [J]. JOURNAL OF THORACIC DISEASE, 2020, 12 (10) : 6240 - 6252
  • [10] Biomarkers for immune checkpoint inhibitors in non-small-cell lung cancer
    Fuschillo, Salvatore
    Battiloro, Ciro
    Rocco, Danilo
    D Gravara, Luigi
    Motta, Andrea
    Maniscalco, Mauro
    [J]. BIOMARKERS IN MEDICINE, 2020, 14 (11) : 929 - 932
12345